Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 27, 2020
Since launching its first site in Preston in North West England in 2019, Panthera has expanded its network of UK clinical trial sites with a new site in North London.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
Monday, November 04, 2019
Independent SMO Panthera Biopartners has opened its first clinical trials site in Preston, Lancashire, UK.
read more
Panthera is on track to have a network of sites open across the UK by the end of the year.
read more
Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS.
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more
Wednesday, February 14, 2024
PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, announced the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in ...
read more
Wednesday, October 26, 2022
Panoramic Health announced the launch of its clinical research division dedicated to advancing kidney care innovation and improving patient outcomes.
read more
Panome Bio has achieved Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art laboratory. This significant accomplishment validates Panome Bio's commitment to the highest standards of quality, accuracy, and ...
read more
Panome Bio has added transcriptional profiling to its suite of discovery tools. The full-service RNAseq workflow is ideal for biomarker discovery and mechanism of action studies and well-suited for integration with Panome Bio's metabolomics and ...
read more
Monday, February 06, 2023
Pangaea Data, (Pangaea), provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, today announced that it has been named “Digital Solution of the...
read more
Virginia Governor Ralph Northam announced that Panaceutics will invest $5.8 million to establish a research and development and high-tech manufacturing facility.
read more
Panacea Biotec has announced a collaboration with Refana USA to make COVID-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland.
read more
PAREXEL and Pamplona Capital Management have entered into an agreement under which Pamplona will acquire all of the outstanding shares of PAREXEL for $88.10 per share in cash in a transaction valued at approximately $5.0 billion, including PAREXEL’s ...
read more
Thursday, January 23, 2020
Palladium Equity Partners has acquired Accupac from J.H. Whitney Capital Partners.
read more